| Name | Apria Healthcare Llc |
|---|---|
| Organization Name | Apria Healthcare Llc |
| Location | 1319 E Ohio St, Clinton, Missouri 64735 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (660) 885-8129 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory can now control how cells connect with one another in vitro and assemble themselves into three-dimensional, multicellular microtissues.
Scientists studying a highly cancer-prone family have identified a rare, inherited gene mutation that dramatically raises the lifetime risk of pancreatic and other cancers.
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
Research into young people's experiences of hair loss during cancer treatment has found it is a mistake to assume women will be more affected than men. Scientists analysing interviews with recovered young adult cancer patients enrolled in the DIPEx project found that young men were just as affected by chemotherapy-induced hair loss as young women.
› Verified 3 days ago
| NPI Number | 1104835529 |
| Organization Name | APRIA HEALTHCARE LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1319 E Ohio St, Clinton, MO 64735 |
| Phone Number | 660-885-8129 |
News Archive
Scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory can now control how cells connect with one another in vitro and assemble themselves into three-dimensional, multicellular microtissues.
Scientists studying a highly cancer-prone family have identified a rare, inherited gene mutation that dramatically raises the lifetime risk of pancreatic and other cancers.
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
Research into young people's experiences of hair loss during cancer treatment has found it is a mistake to assume women will be more affected than men. Scientists analysing interviews with recovered young adult cancer patients enrolled in the DIPEx project found that young men were just as affected by chemotherapy-induced hair loss as young women.
› Verified 3 days ago
News Archive
Scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory can now control how cells connect with one another in vitro and assemble themselves into three-dimensional, multicellular microtissues.
Scientists studying a highly cancer-prone family have identified a rare, inherited gene mutation that dramatically raises the lifetime risk of pancreatic and other cancers.
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
Research into young people's experiences of hair loss during cancer treatment has found it is a mistake to assume women will be more affected than men. Scientists analysing interviews with recovered young adult cancer patients enrolled in the DIPEx project found that young men were just as affected by chemotherapy-induced hair loss as young women.
› Verified 3 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1319 E Ohio St, Clinton, Missouri 64735 Phone: (660) 885-8129 | |
Hanger Clinic Type: Medicare Supplier Location: 702 E Ohio St, Clinton, Missouri 64735 Phone: (660) 885-5512 | |
Physician's Optical Type: Eyewear Supplier (Equipment, not the service) Location: 1602 N 2nd St, Clinton, Missouri 64735 Phone: (660) 885-2020 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 223 E Douglas St, Clinton, Missouri 64735 Phone: (660) 885-4416 | |
Cvs Pharmacy# 10152 Type: Pharmacy Location: 1501e Ohio St, Clinton, Missouri 64735 Phone: (660) 890-0707 |